These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

8325 related items for PubMed ID: 2165192

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Upregulation of bradykinin B2 receptor expression by neurotrophic factors and nerve injury in mouse sensory neurons.
    Lee YJ, Zachrisson O, Tonge DA, McNaughton PA.
    Mol Cell Neurosci; 2002 Feb; 19(2):186-200. PubMed ID: 11860272
    [Abstract] [Full Text] [Related]

  • 25. Characterization of functional nerve growth factor-receptors in a CNS glial cell line: monoclonal antibody 217c recognizes the nerve growth factor-receptor on C6 glioma cells.
    Kumar S, Huber J, Peña LA, Perez-Polo JR, Werrbach-Perez K, de Vellis J.
    J Neurosci Res; 1990 Nov; 27(3):408-17. PubMed ID: 1965839
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Clusterin expression in primary and metastatic melanoma.
    Busam KJ, Kucukgol D, Eastlake-Wade S, Frosina D, Delgado R, Jungbluth AA.
    J Cutan Pathol; 2006 Sep; 33(9):619-23. PubMed ID: 16965336
    [Abstract] [Full Text] [Related]

  • 29. Plasminogen activators, their inhibitors, and urokinase receptor emerge in late stages of melanocytic tumor progression.
    de Vries TJ, Quax PH, Denijn M, Verrijp KN, Verheijen JH, Verspaget HW, Weidle UH, Ruiter DJ, van Muijen GN.
    Am J Pathol; 1994 Jan; 144(1):70-81. PubMed ID: 8291613
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. [The relationship between Fas/FasL and proliferating cell nuclear antigen expression and malignant degree in human melanoma].
    Wang YC, Tan Y.
    Zhonghua Yi Xue Za Zhi; 2008 Apr 08; 88(14):965-8. PubMed ID: 18756968
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Expression of estrogen receptor beta in normal skin, melanocytic nevi and malignant melanomas.
    Ohata C, Tadokoro T, Itami S.
    J Dermatol; 2008 Apr 08; 35(4):215-21. PubMed ID: 18419678
    [Abstract] [Full Text] [Related]

  • 34. Expression of nerve growth factor receptor in human peripheral neuropathies.
    Sobue G, Yasuda T, Mitsuma T, Ross AH, Pleasure D.
    Ann Neurol; 1988 Jul 08; 24(1):64-72. PubMed ID: 2843078
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Immunohistochemical analysis of Bcl-2 protein regulation in cutaneous melanoma.
    Tron VA, Krajewski S, Klein-Parker H, Li G, Ho VC, Reed JC.
    Am J Pathol; 1995 Mar 08; 146(3):643-50. PubMed ID: 7534042
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 417.